Tramadol Hydrochloride Tablet, Film Coated
Product Images NDC 51407-007

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Tramadol Hydrochloride (NDC 51407-007). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Golden State Medical Supply, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

51407-007-01.jpg (51407 007 01)

51407-007-01.jpg (51407 007 01)
Label for Tramadol Hydrochloride 50 mg film-coated tablets from Golden State Medical Supply, Inc., NDC 51407-007. The label indicates a package of 100 tablets, prescription only, with storage instructions and handling warnings. It also includes the drug schedule (C IV) and pharmacist dispensing guidance.*
FDA Label Image

Structural Formula (Tramadol HCl Tablets A075977 Scored 1)

Structural Formula (Tramadol HCl Tablets A075977 Scored 1)
Chemical structure of Tramadol Hydrochloride depicting its molecular components, including aromatic ring, cyclohexane ring, hydroxyl, methoxy groups, and a dimethylamino side chain associated with the hydrochloride salt.*
FDA Label Image

Figure 1 (Tramadol HCl Tablets A075977 Scored 2)

Figure 1 (Tramadol HCl Tablets A075977 Scored 2)
A pharmacokinetic graph displaying plasma concentration (ng/mL) over time (hours) for Tramadol and its metabolite M1 after single and multiple doses. The plot shows concentration decay curves for Tramadol and M1, with separate line styles distinguishing dose types over a 48-hour period.*
FDA Label Image

Figure 2 (Tramadol HCl Tablets A075977 Scored 3)

Figure 2 (Tramadol HCl Tablets A075977 Scored 3)
A line graph titled 'Protocol CAPSS-047' showing time to discontinuation due to nausea/vomiting. The x-axis represents days in double-blind from 0 to 27, and the y-axis shows percent discontinuing from 0 to 55%. Two lines compare 10 days to 200 mg/day (solid line) and 16 days to 200 mg/day (dashed line), illustrating differences in discontinuation rates over time.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.